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This proof-of-concept study examines the feasibility of deﬁning subgroups in psychiatric spectrum disorders by
generative embedding, using dynamical systemmodels which infer neuronal circuitmechanisms fromneuroim-
aging data. To this end, we re-analysed an fMRI dataset of 41 patients diagnosed with schizophrenia and 42
healthy controls performing a numerical n-back working-memory task. In our generative-embedding approach,
we used parameter estimates from a dynamic causal model (DCM) of a visual–parietal–prefrontal network to
deﬁne amodel-based feature space for the subsequent application of supervised andunsupervised learning tech-
niques. First, using a linear support vector machine for classiﬁcation, we were able to predict individual diagnos-
tic labels signiﬁcantly more accurately (78%) from DCM-based effective connectivity estimates than from
functional connectivity between (62%) or local activity within the same regions (55%). Second, an unsupervised
approach based on variational Bayesian Gaussian mixture modelling provided evidence for two clusters which
mapped onto patients and controls with nearly the same accuracy (71%) as the supervised approach. Finally,
when restricting the analysis only to the patients, Gaussian mixture modelling suggested the existence of
three patient subgroups, each of which was characterised by a different architecture of the visual–parietal–
prefrontal working-memory network. Critically, even though this analysis did not have access to information
about the patients' clinical symptoms, the three neurophysiologically deﬁned subgroupsmappedonto three clin-
ically distinct subgroups, distinguished by signiﬁcant differences in negative symptom severity, as assessed on
the Positive and Negative Syndrome Scale (PANSS). In summary, this study provides a concrete example of
how psychiatric spectrum diseases may be split into subgroups that are deﬁned in terms of neurophysiological
mechanisms speciﬁed by a generativemodel of network dynamics such as DCM. The results corroborate our pre-
vious ﬁndings in stroke patients that generative embedding, compared to analyses of more conventional mea-
sures such as functional connectivity or regional activity, can signiﬁcantly enhance both the interpretability
and performance of computational approaches to clinical classiﬁcation.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.
1. Introduction
Psychiatry has experienced a long-standing and ongoing discussion
about the validity of pathophysiological concepts and clinical classiﬁca-
tion schemes. One central problem is that despite all progress in neuro-
science, there has been an almost complete lack of mechanistic insights
that would allow for the development of diagnostic tests for detecting
pathophysiological mechanisms in individual patients. As a result,
with the exception of excluding ‘external’ causes such as brain lesions
or metabolic disturbances (Kapur et al., 2012), psychiatric diagnosis
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still relies on symptom-based deﬁnitions of disease, such as the classiﬁ-
cations proposed by the Diagnostic and Statistical Manual Of Mental
Disorders (DSM) or the International Classiﬁcation of Diseases (ICD).
For example, despite high initial hopes, genetic tests have not en-
tered clinical practice so far (Braff and Freedman, 2008; Tansey et al.,
2012). This is not only because most diseases appear to be highly poly-
genetic, with each candidate polymorphism possibly conveying only a
modest increase in risk (International Schizophrenia Consortium,
2009) and for more than one disease (Cross-Disorder Group Of the Psy-
chiatric Genomics Consortium, 2013). More importantly, genetic tests
are impeded by the presence of strong gene–environment interactions
(Caspi and Mofﬁtt, 2006). These interactions mean that even when
the genome is identical the inﬂuence of different environmental
factors can lead to the occurrence of different disease mechanisms and
symptoms (Dempster et al., 2011; Petronis et al., 2003).
Beyond genetics, neuroimaging is another discipline which has, so
far, struggled to fulﬁl its promise with regard to establishing practically
useful diagnostic tests for psychiatry (cf. Borgwardt et al., 2012). This is
despite the fact that over the past few years, neuroimaging has seen a
veritable explosion in the application to psychiatric questions.
For example, numerous studies have appliedmachine-learning tech-
niques, such as support vector machine (SVM) classiﬁcation, to struc-
tural or functional magnetic resonance imaging (MRI) data. The
majority of previous studies have tried to discriminate patients with a
particular DSM/ICD diagnosis from healthy controls, or to disambiguate
betweenpatients fromdifferentDSM/ICD-deﬁned diseases (see Klöppel
et al., 2012, for a recent review of the application of machine-learning
methods to neuroimaging data of patients). However, for many psychi-
atric diseases, diagnosis with respect to DSM/ICD criteria is not the key
clinical problem (with some notable exceptions, such as distinguishing
between unipolar and bipolar affective psychosis in ﬁrst-episode pa-
tients). Therefore, machine-learning approaches which use diagnostic
labels from DSM/ICD for training a classiﬁer applied to neuroimaging
data can at best reproduce the presently established diagnostic classiﬁ-
cation, but using a considerably more expensive and complicated
procedure.
Instead, it seems more fruitful to develop statistical techniques for
predicting future variables which are important for clinical decision
making, e.g., whether a particular patient with mild cognitive impair-
ment will develop Alzheimer's disease within a certain period or not
(Davatzikos et al., 2008; Lehmann et al., 2012). One prominent hope is
that biological markers derived fromneuroimaging proceduresmay en-
able more accurate predictions of treatment response or disease trajec-
tory than the behavioural and cognitive symptoms on which current
DSM/ICD diagnoses are based.
This approach is logistically considerably more challenging than the
attempt of reproducing DSM-based disease deﬁnitions since it requires
longitudinal studies. Nevertheless, a few recent studies have been able
to demonstrate that it may be possible to predict individual treatment
response (e.g., Costafreda et al., 2009; Liu et al., 2012; Szeszko et al.,
2012) or clinical outcome (e.g., Koutsouleris et al., 2012; Mourao-
Miranda et al., 2012; Siegle and Thompson, 2012) from structural or
functional MRI data, using multivariate classiﬁcation. If such a proce-
dure could be established that allowed, with sufﬁcient sensitivity and
speciﬁcity, for clinically relevant decisions, it might indeed become a
cost-effective tool for clinical decision-making. Still, however, any such
approach would effectively remain a ‘black-box’ classiﬁer, providing
very limited insights, if any, into disease mechanisms. This is a funda-
mental limitation, since without mechanistic interpretability no diag-
nostic procedure can inform a change in disease concepts or guide the
development of future therapies.
A potential alternative to black-box classiﬁcation is to embed classi-
ﬁcation into a space spanned by the parameters of a generative model
which explains how themeasured data could have arisen from underly-
ing neurophysiologicalmechanisms (e.g., synaptic connections between
distinct neuronal populations). This is the generative-embedding
approach which we recently introduced to neuroimaging (Brodersen
et al., 2011a).
In this previous work, we demonstrated that a six-region dynamic
causal model (DCM) of the early auditory system during passive speech
listening could predict, with near-perfect accuracy (98%), the absence or
presence of a ‘hidden’ (i.e., outside the ﬁeld of view) lesion in aphasic
patients compared to healthy controls. Critically, this model-based clas-
siﬁcation approach not only signiﬁcantly outperformed conventional
approaches, such as searchlight classiﬁcation on the raw fMRI data or
classiﬁcation based on functional connectivity between the same re-
gions; more importantly, it also highlighted network mechanisms
which distinguished the two groups. In this case, the connections from
the right to the left hemisphere were particularly informative for
enabling this subject-by-subject classiﬁcation, suggesting that the
remote lesion prominently affected interhemispheric transfer of lan-
guage information to the dominant hemisphere.
Mechanistically interpretable approaches like generative embed-
ding have potential for signiﬁcantly enhancingmodel-based predictions
of clinically relevant variables such as outcome or treatment response.
However, these approaches are of equal importance for addressing a
second fundamental problem in psychiatry: the nature of psychiatric
nosology itself, i.e., the disease deﬁnitions that determine clinical diag-
nostics and classiﬁcation. As described above, DSM deﬁnes diseases
purely on the basis of symptoms that can be assessed by means of
structured interviews. This approach was introduced a few decades
ago to ensure the reproducibility of diagnostic statements across clini-
cians and institutions. However, the consequence of its entirely phe-
nomenological nature is that the resulting disease concepts are
completely agnostic about underlying mechanisms. Furthermore,
many empirical studies have questioned the clinical validity of this clas-
siﬁcation scheme, demonstrating problematic predictive validity with
regard to treatment and outcome (e.g., Johnstone et al., 1988;
Johnstone et al., 1992). It is therefore not surprising that this phenome-
nological deﬁnition of diseases has received substantial criticism, and al-
ternatives are being sought, such as the Research Domain Criteria
(RDoC; Insel et al., 2010) which aim to redeﬁne psychiatric diseases
based on pathophysiological mechanisms. Key challenges for this en-
deavour are how such pathophysiological mechanisms can be detected
in the individual, and how they are combined to produce a meaningful
classiﬁcation.
We have previously argued that a pathophysiologically informed
dissection of psychiatric spectrum diseases, such as schizophrenia, into
physiologically deﬁned subgroups should be guided by model-based
estimates of synaptic physiology fromneuroimaging and electrophysio-
logical data (Stephan, 2004; Stephan et al., 2009). This approach
requires modelling techniques which can be applied to non-invasive
measures of brain activity in individual patients and which are capable
of inferring neurophysiological mechanisms at the circuit level. One
such method is dynamic causal modelling (DCM; Friston et al., 2003),
a Bayesian framework for inferring neurophysiological mechanisms
from neuroimaging data.
Previous electrophysiological studies have demonstrated that DCM
can provide valid information on mechanisms which represent poten-
tial key dimensions of psychiatric disease, e.g., excitation–inhibition bal-
ance, synaptic plasticity by NMDA receptors, or its regulation by
neuromodulatory transmitters such as dopamine or acetylcholine
(Moran et al., 2011a,b; Schmidt et al., 2012). When applied to fMRI
data, DCM allows for less ﬁne-grained representation of physiological
mechanisms and is largely restricted to inferring on synaptic coupling
between large, undifferentiated neuronal populations. Nevertheless,
even this coarse physiological representation has proven useful for
distinguishing groups with different cognitive or disease states, such
as: the presence vs. absence of a ‘hidden’ lesion (see above; Brodersen
et al., 2011a,b); Parkinson patients on vs. off dopaminergic medication
(Rowe et al., 2010); individuals with different types of synaesthesia
(Van Leeuwen et al., 2011); patients suffering from depression vs.
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healthy controls (Desseilles et al., 2011); or congenitally blind vs. late-
onset blind individuals (Collignon et al., 2013).
Using DCM as the basis for generative embedding is therefore an
attractive approach for establishing clinically relevant ‘model-based
assays’ that can characterise, in an unsupervised fashion, patient sub-
groups by differences in circuit-level mechanisms. The present study
provides a ﬁrst proof of concept that illustrates the plausibility of this
notion in a patient sample.
In the ﬁrst part of this paper, we review key concepts of generative
embedding and introduce procedures that are speciﬁc for its application
in an unsupervised context, i.e., model-based clustering. Keeping a clin-
ical audience in mind, we have written this Methods section in a
tutorial-like fashion wherever possible. We then present a concrete
example where we examine whether schizophrenia patients can be
classiﬁed into subgroups that are distinguished by different neurophys-
iological mechanisms underlying working memory. To this end, we
used fMRI data from 41 schizophrenic patients and 42 healthy controls
during a visual working-memory task which had previously been
characterised by a three-region DCM of neuronal dynamics in a visual–
parietal–prefrontal network (see Deserno et al., 2012, for the original
analysis).
Working memory is a useful construct for testing the feasibility of
model-based clustering of schizophrenia patients, given that it is a
core component of cognitive control which is frequently disturbed in
schizophrenia (Lee and Park, 2005). Cognitive deﬁcits in the domain
of working memory have also become a primary research target
(Barch et al., 2012; Lewis and Gonzalez-Burgos, 2006) since they have
been shown to be a major predictor of clinical outcome (Bowie et al.,
2008; Nuechterlein et al., 2011; Shamsi et al., 2011; Vesterager et al.,
2012), a predictor of the transition from an at-risk mental state to the
onset of the disease (Fusar-Poli et al., 2012), and, given their presence
in ﬁrst-degree relatives, potentially indicative of vulnerability (Snitz
et al., 2006).
Using the subject-speciﬁc posterior parameter estimates of the orig-
inal model as the basis for generative embedding, we address three
questions. First, does this simple three-region DCM enable above-
chance classiﬁcation of individual subjects, distinguishing successfully
between patients and controls, and if so, how does it compare to classi-
ﬁcation based on functional connectivity and regional activity? Second,
ifwe disregard all knowledge about thediagnostic status of our subjects,
will an unsupervised clustering approach operating on the DCM
parameter estimates recognise the presence of two groups, i.e., patients
and controls? And ﬁnally, focusing on the patients only, is there evi-
dence for neurophysiologically deﬁned subgroups within the schizo-
phrenic spectrum that are distinguished by differential network
mechanisms and are related to independent clinical variables?
2. Methods
Model-based clustering by generative embedding comprises six
steps: (i) extraction of time series; (ii) generative modelling and
model inversion; (iii) embedding in a generative score space; (iv) clus-
tering, including model-order selection; (v) validation with respect to
independent criteria such as clinical information; and (vi) interpreta-
tion of the neurophysiological mechanisms (encoded by the parameter
estimates) that deﬁne the identiﬁed subgroups. This section describes
these steps in detail (Fig. 1).
2.1. Extraction of time series
The ﬁrst step in a generative-embedding analysis concerns the ex-
traction of data features that will be subject to modelling. In this
paper, we illustrate generative embedding for fMRI data, adopting the
same approach to time-series extraction as used previously in the con-
text ofmodel-based classiﬁcation (Brodersen et al., 2011a,b). Speciﬁcal-
ly, we begin by specifying a set of regions of interest (ROIs), which could
be deﬁned anatomically or bymeans of a functional contrast. The choice
of these regions is informed by pre-existing concepts which relate
speciﬁc neuronal circuits to the expression of speciﬁc cognitive pro-
cesses or behavioural symptoms. For example, the empirical applica-
tion described below focuses on a visual–parietal–prefrontal
network. These are regions whose involvement in visual working
memory is well-established (see Rottschy et al., 2012, for a compre-
hensive meta-analysis of fMRI studies of working memory); in turn,
working memory is a core component of cognitive control which is
frequently disturbed in schizophrenia (Lee and Park, 2005). Follow-
ing the deﬁnition of this network, we compute, for each region, the
ﬁrst eigenvariate based on all voxels contained in that region,
which yields a region-speciﬁc representative time course of blood
oxygen level dependent (BOLD) activity.
In order to enable an unbiased clustering analysis, it is important
that the selection of time series is not based on information that is
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Fig. 1. Conceptual overview ofmodel-based clustering by generative embedding. This schematic illustrates how generative embedding enables model-based clustering of fMRI data. First,
separately for each subject, BOLD time series are extracted from a number of regions of interest. Second, subject-speciﬁc time series are used to estimate the parameters of a generative
model. Third, subjects are embedded in a generative score space in which each dimension represents a speciﬁc model parameter. This space implies a similarity metric under which any
two subjects can be compared. Fourth, a clustering algorithm is used to identify salient substructures in the data. Fifth, the resulting clusters are validated against known external (clinical)
variables. Once validated, a clustering solution can, sixth, be interpreted mechanistically in the context of the underlying generative model.
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related to the differences (e.g., group membership) which we hope to
disclose by clustering. For example, when assessing how well an unsu-
pervised clustering procedure assigns patients and controls to their
respective categories, between-group contrasts should not be used for
the deﬁnition of regions of interest. In previous work, we analysed in
detail which procedures for choice of regions and time-series extraction
ensure unbiased results in analyses where generative embedding is
used for model-based classiﬁcation (Brodersen et al., 2011a,b). Here,
we extend this analysis to model-based clustering.
As illustrated in Fig. 2, unbiased estimates of the external validity of a
clustering solution can be obtainedwhen time series are selected on the
basis of anatomical contrasts (Fig. 2A) or functional contrasts that are
unrelated to the variable used for external validation (Fig. 2B). By con-
trast, the use of the external variable itself (or a variable that is correlat-
ed with it) would introduce circularity and may easily lead to an
overoptimistic estimate of cluster validity (Fig. 2C). For example, using
a ‘patient–controls’ contrast for regional time-series selection should
be avoided when the subsequent clustering is to be evaluated w.r.t. dis-
ease state; in such a case, it would simply not be surprising if the obtain-
ed clusters could be mapped accurately onto the groups of patients and
controls. In the present study, regions of interest were therefore deﬁned
both anatomically and functionally without reference to clinical vari-
ables used for validation.
2.2. Generative modelling and model inversion
Generative embedding rests on the speciﬁcation and inversion of a
generative model of the data. In brief, a generative model encodes a
mechanistic process of how data or measurements arise by combining
a prior distribution (on parameters and/or states) with a likelihood
function (Bishop, 2007). As in our previous publication (Brodersen
et al., 2011a,b), we use a DCM of fMRI data (Friston et al., 2003). DCM
regards the brain as a nonlinear dynamical system of neuronal popula-
tions that interact via synaptic connections, and an experiment as a
designed perturbation of the system's dynamics (for a conceptual over-
view of DCM, see Stephan et al., 2010). While the mathematical formu-
lation of DCMs varies across measurement types, commonmechanisms
modelled by all DCMs include synaptic connection strengths and exper-
imentally induced modulation thereof (e.g., Chen et al., 2008; David
et al., 2006; Daunizeau et al., 2009; Moran et al., 2009; Stephan et al.,
2008). Generally, DCMs strive for neurobiological interpretability of
their parameters; this is one core feature distinguishing them from
most alternative approaches to modelling neuroimaging data. The
physiological interpretability of DCMsmakes them a particularly attrac-
tive candidate for generative embedding.
DCMs are hierarchical models with at least two layers. The ﬁrst layer
is a neuronal model, describing the dynamics of interacting neuronal
populations under the inﬂuence of experimentally controlled perturba-
tions. Its parameters are neurobiologically interpretable to somedegree,
representing, for example, synaptic weights and their context-speciﬁc
modulation. Experimental manipulations u enter the model either by
eliciting responses through direct inﬂuences on speciﬁc regions (e.g.,
sensory inputs) or by modulating the strength of coupling among re-
gions (e.g., short-term synaptic plasticity due to task demands or
learning).
In this paper, we will use the classical bilinear DCM for fMRI (Friston
et al., 2003) as implemented in the software package SPM8/DCM10
(r4290). Its neuronal model rests on a deterministic ordinary differen-
tial equation
dx tð Þ
dt
¼ f x tð Þ; θn;u tð Þð Þ ¼ Aþ∑ ju j tð ÞB jð Þ
 
x tð Þ þ Cu tð Þ ð1Þ
which represents a low-order approximation to any nonlinear dynami-
cal system with known perturbations (Stephan et al., 2008). Here, x(t)
is the neuronal state vector x at time t, A is a matrix of endogenous
(ﬁxed) connection strengths, B(j) represents the additive change of
these connection strengths induced by modulatory input uj, and C
denotes the strengths of direct (driving) inputs.
The second layer of a DCM is a biophysically motivated forward
model that describes how a given neuronal state translates into a mea-
surement. The exact form of the model depends on the measurement
modality. In the case of fMRI, the haemodynamic forward model can
be written as
y tð Þ ¼ g x tð Þ; θhð Þ þ  ð2Þ
where g(⋅) is a nonlinear operator that translates a neuronal state x(t)
into a predicted BOLD signal via changes in vasodilation, blood ﬂow,
blood volume, and deoxyhaemoglobin content (see Stephan et al.,
2007, for details). The forward model has haemodynamic parameters θh
and Gaussian measurement error . The haemodynamic parameters pri-
marily serve to account for variations inneurovascular coupling across re-
gions and subjects and are typically not of primary scientiﬁc interest. In
addition, the haemodynamic parameters exhibit fairly strong inter-
dependencies (high posterior covariances; Stephan et al., 2007), which
CB
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Fig. 2.Options for network construction for generative embedding. An important design decision inmodel-based clustering analyses is the criterion by which regional time series are ex-
tracted from the data. One option is to deﬁne regions anatomically, followed by the separate inversion of themodel for each subject. A clustering solution obtained in this way can be safely
evaluated with respect to an external variable (Procedure a). A frequent alternative is to deﬁne regions in terms of a functional contrast. As before, models are inverted in a subject-by-
subject fashion (Procedure b). This allows for an unbiased estimate of the external validity of the resulting clustering solution but requires, critically, that the functional contrast not be
based on the same variable that is used for external validation (Procedure c).
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makes it difﬁcult to establish the distinct contribution afforded by each
parameter. For these reasons, the model-based clustering analyses in
this paper will be based exclusively on the neuronal parameters θn.
DCM uses a fully Bayesian approach to parameter estimation, with
physiologically informed priors for the haemodynamic parameters
and zero-mean priors for the coupling parameters (Friston et al.,
2003). Combining the prior density over the parameters p(θ|m) with
the likelihood function p(y|θ, m) yields the posterior density p(θ|y, m).
This inversion can be carried out efﬁciently by maximising a variational
free-energy bound to the log model evidence, ln p(y|m), under
Gaussian assumptions about the posterior (the Laplace assumption;
see Friston et al., 2006, for details). Given d parameters, model inver-
sion thus yields a subject-speciﬁc multivariate normal probability
density q θjμ^;∑^
 
≈p θjy;mð Þ that is fully described in terms of a vec-
tor of posterior means μ^∈ℝd and a covariance matrix ∑^∈ℝdñd .
Model inversion proceeds in an unsupervised and subject-by-
subject fashion, i.e., in ignorance of clinical labels that may later be
used in the context of classiﬁcation or clustering.
In summary, DCM provides a generative model for explaining mea-
sured time series of brain activity as the outcome of hidden dynamics
in an interconnected network of neuronal populations under the inﬂu-
ence of experimentally induced perturbations. Inverting such a model
means inferring the posterior distribution of the parameters of both
the neuronal and the forward model from observed responses of a spe-
ciﬁc subject. Due to its physiological interpretability and applicability to
single-subject data, DCM has previously been successfully used in
model-based classiﬁcation (Brodersen et al., 2011a,b) and is an equally
attractive candidate for model-based clustering.
2.3. Embedding in a generative score space
To obtain a clustering of subjects, one might think of representing
each subject as a vector of voxel-wise activity over time. Such a feature
space would retain all information we have measured across the whole
brain. However, this is neither statistically feasible (because the number
of features per subject would vastly exceed the number of subjects) nor
conceptually desirable as such an overly rich representation will not
only include features that are relevant for the purpose of clustering
(i.e., pathophysiological processes) but also many irrelevant distractors
andmeasurement noisewhichwill decrease performance. This problem
of feature selection poses a key research theme inmachine learning and
requires appropriate techniques for dimensionality reduction. One at-
tractive option is to embed thedata in a feature space that is constructed
using a generative model (Lasserre et al., 2006; Martins et al., 2010;
Minka, 2005; Perina et al., 2010). This feature space, referred to as a gen-
erative score space, embodies a model-guided dimensionality reduction
of the observed data.
In the context of DCM, a straightforwardway of creating a generative
score space is to consider the posterior expectations of model parame-
ters of interest (e.g., parameters encoding synaptic connection
strengths). More formally, we can deﬁne a mappingℳΘ → ℝd that
extracts a subset of point estimates μ^ :¼ θjx;m from the posterior distri-
bution p(θ|x, m). This simple d-dimensional vector space represents a
selective summary of network mechanisms (e.g., connection strengths
between regions but not haemodynamic parameters), as opposed to ac-
tivity levelswithin these regions. Additionally, one could incorporate el-
ements of the posterior covariance matrix into the vector space. This
would be beneﬁcial if class differences were revealed by the precision
with which connection strengths can be estimated from the data.
It is worth emphasising that, because a generative-embedding ap-
proach rests upon a mechanistically motivated dynamical systems
model, a model-based feature space of the sort described above is im-
plicitly based on a highly nonlinear mapping: from individual measure-
ment time points to posterior parameter expectations of an underlying
dynamical system. In addition, the generative score space is not just
driven by thedata themselves; because the generativemodel is inverted
in a fully Bayesian fashion, the resulting space incorporates all the do-
main knowledge that drove the speciﬁcation of prior densities over
model parameters. These aspects may be critical when aiming for an in-
terpretable clustering solution, as described next.
2.4. Clustering
Our approach rests on the model-guided creation of a generative
score space. In principle, subsequent clustering can then be carried out
in this space using any established clustering technique. However, in
the context of dissecting psychiatric spectrum diseases, an important
challenge is to infer on the most likely number of subgroups which
are not known a priori. This advocates the use of clustering techniques
that evaluate the relative goodness of different clustering solutions, for
example by model selection.
A suitable technique for inferring on the number of clusters via
model selection is the variational inversion of a Gaussian mixture
model (GMM). In this model, the likelihood of an individual subject's
data xi is given by
p xijzi; μ;Λð Þ ¼
XK
k¼1N xijμk;Λ
−1
k
 zi;k
: ð3Þ
The above formulation corresponds to a clustering model with K
clusters, deﬁned in terms of means μk and precision (or inverse covari-
ance) matrices Λk. The latent variable zi has a 1-of-K encoding and indi-
cates which cluster the data xi belong to:
p zijπð Þ ¼∏Kk¼1πzi;kk : ð4Þ
The mixing coefﬁcients π denote the relative contribution of differ-
ent clusters to the data. Thus, the log likelihood of an entire dataset
(of i.i.d. subjects) X is given by
lnp XjZ; μ;Λð Þ ¼
Xn
i¼1 ln
XK
k¼1N xijμk;Λ
−1
k
 zi;k
: ð5Þ
One approach to estimating the parameters of the abovemodel is via
the expectation–maximisation (EM) algorithm, an iterative framework
for ﬁnding maximum-likelihood parameter estimates of models with
latent variables (such as cluster assignments). This approach is simple
and powerful; however, it risks overﬁtting the data and can be prone
to singularities (when a Gaussian component collapses onto a single
data point, causing the log likelihood function to diverge to inﬁnity).
In addition, a maximum-likelihood formulation of a GMM assumes
that the optimal number of the Gaussian components is known a priori.
To avoid the above limitations, we use a variational Bayesian ap-
proach to inverting a GMM (Attias, 2000; Bishop, 2007). This approach
eschews the problem of singularities by introducing a suitable prior
over the parameters (see Appendix A for details). When using this
prior, the only approximating assumption required to obtain a varia-
tional solution is the mean-ﬁeld assumption
q Z;π; μ;Λð Þ ¼ q Zð Þq π; μ;Λð Þ; ð9Þ
where q(⋅) is the desired variational approximation to the true posterior
p(⋅|X). This approach also allows us to determine the optimal number of
clusters by means of Bayesian model selection. Speciﬁcally, we can
compute a free-energy bound to the log model evidence, or marginal
likelihood,
F q;Xð Þ≈ lnp Xð Þ
≈ ln∭p XjZ;π; μ;Λð Þp Z; π; μ;Λð Þd Zd πd μd Λ ; ð10Þ
which denotes the likelihood of a model (here: of the cluster structure)
given an observed dataset X. It represents a principled measure of
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model goodness that trades off accuracy (model ﬁt) againstmodel com-
plexity (MacKay, 1992; Penny et al., 2004). Typically, a log evidence dif-
ference higher than 3 is considered to represent strong evidence in
favour of one model relative to another (Kass and Raftery, 1995);
when comparing two models, this corresponds to a posterior probabil-
ity of the ﬁrst model, given the data, higher than 95%. In the context of
our application, by comparing the (approximate) log evidence of differ-
entGaussianmixturemodels, each assuming a different number of clus-
ters, we can evaluate the relative plausibility of different cluster
solutions in a principled way based on probability theory, optimizing
the trade-off between accuracy (ﬁt) and model complexity and thus
preventing overﬁtting.
2.5. Validation
As explained above, the clustering solution with the highest model
evidence yields the most likely substructure given the data and the
GMM assumptions. However, any proposed clustering solution remains
an untested hypothesis unless we explicitly validate it against a known
structure that is external to the clustering model itself. We therefore
have to assess explicitly how well a given clustering solution matches
an external criterion (which is independent from the actual data on
which clustering was performed), such as clinical status or treatment
response. If the external criterion is of a categorical nature, this can
be done, for instance, by computing the purity of the solution (e.g.,
Manning et al., 2008).
Informally, purity measures how homogeneous the obtained clus-
ters are. A perfectly homogeneous cluster contains only subjects from
the same class; whereas a heterogeneous cluster contains a mixture of
data points from different classes. Homogeneous clusters indicate that
the clustering solution has picked up the implicit grouping structure de-
ﬁned by the external variable (which, critically,must have been unavail-
able to the clustering procedure itself). To compute the purity of a
solution, all data points are assigned to the class label that occurs most
frequently in the associated cluster. Purity is then calculated as
purity Ω;ℂð Þ :¼ 1
n
XK
k¼1 max j ωk∩c j
 ; ð13Þ
where Ω = (ω1,ω2, …,ωk) represents the clustering solution such that
ω1 contains the indices of all those subjects for which the ﬁrst cluster
had the highest posterior probability. Given the set of external (true)
class assignments ℂ = (c1,c2, …,cj), the term |ωk ∩ cj| represents the
number of subjects in cluster k with external label j. Normalised by
the number of subjects n, purity thus is a number between 0 and 1
and indicates the degree to which the obtained clustering solution
agrees with grouping structure implied by an external categorical
variable.
One limitation of the deﬁnition in Eq. (13) is its misleading nature
when applied to imbalanced datasets where different subgroups vary
in the number of subjects they contain. The underlying issue is exactly
the same as with classiﬁcation accuracy, which is a misleadingmeasure
of classiﬁcation performance when the data are not perfectly balanced.
In these cases, the balanced accuracy is a more useful performancemea-
sure as it removes the bias that typically arises when applying a classiﬁ-
cation algorithm to an imbalanced dataset (Brodersen et al., 2010).
Here, we introduce the same idea to provide a bias correction for the
purity of a clustering solution. Speciﬁcally, we deﬁne the balanced purity
as
bp Ω;ℂð Þ :¼ 1−1
n
 
purity Ω;ℂð Þ−ξ
1−ξ
 
þ 1
n
: ð14Þ
In the above expression, ξ is the degree of imbalance in the data, deﬁned
as the fraction of subjects associated with the largest class (i.e.,
0.5 ≤ ξ b 1). When cluster assignments perfectly agree with the
external variable, the balanced purity is 1. By contrast, when cluster as-
signments are random, the quantity drops to 1/K (e.g., 0.25 if the exter-
nal variable deﬁnes 4 groups). In this way, the balanced purity can be
interpreted in the same way as the (balanced) accuracy of a classiﬁca-
tion algorithm: it indicates the probability with which a new subject
with a particular label would be assigned to a cluster in which the ma-
jority of subjects are associated with that exact same label.
Rather than deﬁning discrete categories, external variables may
sometimes be continuous. For example, we might want to assess to
what extent an obtained clustering solution is related to a (continuous)
measure of clinical symptoms or outcome. In the case of a continuous
external variable, the concept of purity no longer applies. Instead, we
can validate a solution by attempting to reject the (null) hypothesis,
using a one-way ANOVA, that the latent distribution of the external var-
iable has the samemean in all clusters. In the next section, wewill pres-
ent examples of both categorical and continuous variables for external
validation of a clustering solution.
3. Results
To demonstrate the potential utility of model-based clustering in a
clinical setting, we reanalysed a previously published fMRI dataset
with n = 83 subjects, consisting of: (i) a group of 41 patients diagnosed
with schizophrenia according to DSM-IV (10 female; mean age
34.1 years; SD 10.4); and (ii) a group of 42 healthy controls (19 female;
mean age 35.4; SD 12.3). A brief summary of patient demographics, the
task, data acquisition, and preprocessing is provided below; we refer to
Deserno et al. (2012) for more detailed information on all of these
aspects.
35 patients received treatment with typical antipsychotic medica-
tion (haloperidol 22; ﬂupenthixol 10; ﬂuphenazine 2; perazine 1);
ﬁve patients were medicated with atypical drugs (aripriprazole 2;
olanzapine 2; risperidon 1); and one patient did not receive any medi-
cation. The mean medication dosage was 523.3 ± 316.3 mg (mean ±
SD) in chlorpromazine equivalents. Psychopathological symptoms
were assessed with the positive and negative syndrome scale (PANSS)
(Kay et al., 1987), showing a mean total PANSS score of 78.9 ± 28.2
(positive symptoms: 20.2 ± 8.0; negative symptoms: 20.2 ± 8.5; gen-
eral psychopathology 37.8 ± 15.0). The patients had a mean illness
duration of 5.8 ± 6.8 years, a mean age of onset of 28.6 ± 8.6 years,
and a mean number of 3.1 ± 3.1 episodes.
Subjects were engaged in a numeric n-back working-memory task
with two blocked conditions: in the ‘2-back’ condition, a button press
was required when the current number was identical to the number
two trials ago; in the ‘0-back’ condition, a button press was required
every time the number zero appeared. Each condition was presented
PC dLPFC
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WM
stimulus
Fig. 3.Thedynamic causalmodel thatwas chosen as a basis for generative embedding. This
ﬁgure summarises the structure of the three-region DCM suggested by Deserno et al.
(2012). The model consists of visual, parietal, and prefrontal regions. Trial-speciﬁc visual
information is modelled to provide driving input for visual cortex, whereas working-
memory demands (2-back condition) are allowed to alter the strength of visual–prefrontal
and prefrontal–parietal connections.
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in six blocks of 22 trials each, with three targets per block. Each number
was displayed for 500 ms, separated by a 900 ms inter-stimulus inter-
val. Task blocks were alternated with resting blocks during which only
visual ﬁxation was required.
Functional imaging data were acquired on a 1.5 T MRI scanner (Sie-
mens Magnetom Vision) using whole-brain gradient-echo echo-planar
imaging (TR 2600 ms; TE 40 ms; ﬂip angle 90°; matrix 64 × 64; voxel
size 4 × 4 × 5.5 mm3). Following spatial preprocessing including
realignment, normalisation to the Montreal Neurological Institute
(MNI) template, and smoothing using an isotropic Gaussian kernel
(FWHM 8 mm), a standard mass-univariate voxel-wise analysis was
performed using a general linear model (GLM), followed by DCM and
Bayesian model selection (BMS); the results are described in Deserno
et al. (2012).
Here, we re-examined this dataset using the procedure shown in
Fig. 1 and the DCM shown in Fig. 3. This DCM is the model that
Deserno et al. (2012) found to have the highest evidence in the left
hemisphere when pooling over healthy volunteers and patients. Note
that this model comparison did not concern group discriminability but
assessed how well different models explained the measured data (i.e.,
regional time series) per se, regardless of group membership. Regions
of interest were deﬁned anatomically and functionally without refer-
ence to any of the variables that would later be used for external valida-
tion, corresponding to the unbiased procedures shown in Fig. 2A,B.
Model inversion was carried out separately for each subject, follow-
ed by the construction of a generative score space on the basis of the
posterior means of all neuronal model parameters. The resulting space
contained 12 features: 6 interregional connections; 3 self-connections
(Amatrix); 2 modulatory parameters (Bmatrix); and 1 visual input pa-
rameter (Cmatrix).
Using this model-based feature space, we applied both supervised
(SVM) and unsupervised (GMM) learning techniques to address the
three questions outlined in the Introduction: does our rather simple
three-region DCM classify patients and controls with above-chance
accuracy? Second, when considering all subjects, will unsupervised
clustering correctly indicate the presence of two major groups, i.e., pa-
tients and controls? And ﬁnally, focusing on the patients only, is there
evidence for neurophysiologically deﬁned subgroupswithin the schizo-
phrenic spectrum?
One important subtlety is that the initial modelling results obtained
by DCM might be affected by other factors than processes related to
diagnostic status. We therefore regressed out sex, handedness, and age,
using a separate multiple linear regression model for each model pa-
rameter. Thus, model-based classiﬁcation was carried out on the resid-
uals of parameter estimates after removing the potential confounds
listed above. It is worth noting at this stage that neither medication
nor symptom severity were considered as confounds, but as external
variables of interest against which the interpretability of the proposed
cluster solution was evaluated (see below).
3.1. Model-based classiﬁcation
Before turning to model-based clustering, we initially adopted a su-
pervised approach and used a classiﬁcation algorithm to distinguish be-
tween patients and healthy controls. Followingour previously published
procedure of generative embedding for model-based classiﬁcation
(Brodersen et al., 2011a,b), we used the posterior expectations of DCM
parameter estimates for training and testing a linear support vector
machine as implemented in LIBSVM (Chang and Lin, 2011) on subject-
speciﬁc connectivity patterns, using 5-fold cross-validation. Prior to clas-
siﬁcation, all DCM parameters were centred and standardized to have a
mean of 0 and a standard deviation of 1 across subjects.
The algorithmwas able to separate patients and controls with a bal-
anced accuracy of 78% (Fig. 4a).We evaluated the signiﬁcance of all clas-
siﬁcation results by considering the posterior distribution of the
balanced accuracy in a Bayesian beta-binomial model with a ﬂat prior
(see Brodersen et al., 2010, 2013, for details). Under a Bayesian view,
signiﬁcance is assessed by considering the area under the posterior den-
sity below chance, which we refer to as the posterior infraliminal prob-
ability p. This probability has a more intuitive interpretation than a
classical p-value. Rather than denoting the probability of observing the
data (or more extreme data) under the ‘null hypothesis’ of a chance
classiﬁer (classical p-value), the infraliminal probability represents the
(posterior) probability that the classiﬁer operates at or below chance
(cf. Brodersen et al., 2012). For the classiﬁcation result of 78% reported
above, this infraliminal probability was p b 0.001, i.e., classiﬁcation per-
formance was highly signiﬁcant.
We compared this result to an alternative approach in which the
classiﬁer operated on estimates of functional connectivity (Craddock
et al., 2009) rather than posterior means of effective connectivity esti-
mates. Following standard practice, functional connectivity was com-
puted in terms of Pearson correlation coefﬁcients among the same
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Fig. 4.Model-based classiﬁcation and clustering of all subjects. Fig. 4a shows the result of a supervised classiﬁcation analysis under 5-fold cross-validation. It can be seen that schizophrenic
patients can be best distinguished from healthy controls using generative embedding; this performance was signiﬁcantly higher compared to classiﬁcation based on functional connec-
tivity or regional activity (see main text for details). Panel b illustrates which model parameters differed signiﬁcantly between patients and controls (two-sample t-tests on individual
model parameters with Bonferroni correction for multiple tests), thus contributing most strongly to the classiﬁcation result. Panel c reports the results of an unsupervised analysis,
using a variational Bayesian Gaussian mixture model that operates on DCM parameter estimates. This analysis ﬁnds the highest evidence for a model consisting of two clusters. These
two clusters correspond to patient and control groups with almost the same accuracy as the supervised classiﬁcation analysis (see main text for details).
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eigenvariates of BOLD time series which had been used for DCM. This
approach yielded a classiﬁcation accuracy of 62%. While this was still
signiﬁcantly above chance (p b 0.05; infraliminal probability), it was
signiﬁcantly outperformed (p b 0.01; Wald test) by generative embed-
ding. Finally, we also tested towhat extent classiﬁcationwas possible on
the basis of activity levels in the three regions, as encoded by three re-
gional means and three regional standard deviations of GLM parameter
estimates. This variant resulted in an accuracy of only 55%, indistin-
guishable from chance performance (p = 0.15; i.p.) and signiﬁcantly
worse (p b 0.001; Wald test) than model-based classiﬁcation.
These results concur with our earlier ﬁndings for model-based clas-
siﬁcation of stroke patients (Brodersen et al., 2011a,b) in the sense that
a reasonably good generative model can lead to signiﬁcantly improved
classiﬁcation performance compared to classiﬁcation procedures
based on descriptive indices such as functional connectivity or regional
activity. We discuss the reasons for this superiority of the model-based
approach in detail in the Discussion section.
Above and beyond classiﬁcation accuracy, an advantage of a model-
based analysis is that its results can be interpreted in the context of the
underlying generative model. To illustrate this, we asked which param-
eters were most powerful in distinguishing between patients and
healthy controls. A simple way of addressing this question is by means
of two-sample t-tests on individualmodel parameters (while correcting
for multiple tests). This analysis showed that the self-connections of all
three regions were signiﬁcantly discriminative, as was the effective in-
ﬂuence exerted by VC onto dLPFC and the connections between dLPFC
and PC in either direction (Fig. 4b; p b 0.05; Bonferroni-corrected for
multiple tests). By contrast, parameters such as the strength of the stim-
ulus input (C vector) were not found to be signiﬁcantly discriminative.
The above supervised (classiﬁcation) analyses are interesting for
comparative purposes and were conducted to verify that our fMRI
data and chosen model contain meaningful information about disease
state at all. However, we would like to reiterate that these classiﬁcation
analyses are not of primary interest for our present study. Rather than
trying to replicate known diagnostic labels based on DSM-IV by fMRI
and modelling (which has little priority given the ease with which
schizophrenia is diagnosed clinically and the limited predictive validity
of DSM categories; see Introduction), the key question we were inter-
ested in was whether the schizophrenia spectrum deﬁned by DSM-IV
can be dissected into patient subgroups characterised by distinct neuro-
physiological mechanisms, as encoded by the parameter estimates of
ourDCMofworkingmemory. This questionwas addressed by the unsu-
pervised (clustering) analyses presented in the following sections.
3.2. Model-based clustering of all subjects
Using the GMM algorithm described in the Methods section, we ini-
tially performed a model-based clustering analysis of all subjects, based
on their posterior DCM parameter estimates. The purpose of this initial
unsupervised analysis was to assess whether our model would be sufﬁ-
ciently sensitive to detect the difference between patients and healthy
controls, in the absence of any a priori knowledge about the existence
of these two groups. Indeed, we found that the highest model evidence
was obtained by a Gaussian mixture model with two clusters (Fig. 4c).
This model outperformed the next-best model by a log Bayes factor
(BF) of 64.3, implying very strong evidence that a model with two clus-
ters provided the best explanation of the variability observed across
subjects.
Evaluating the validity of the obtained clustering solution against the
known diagnostic labels (i.e., healthy vs. diagnosed) yielded a balanced
purity of 71% (Fig. 4c). That is, the unsupervised assignment of subjects
to patient and control groups was almost as good as in the supervised
case which had access to considerably more information (namely, that
two groups existed, and which subject belonged to which).
To evaluate to what extent the two approaches agreed with regard
to individual subjects, we compared the set of subjects that were
misclassiﬁed to the set of subjects that were ‘misclustered’, in the
sense of representing the minority class in their cluster. As expected,
the two sets overlapped to a large extent. Speciﬁcally, whether or not
a subjectwas classiﬁed correctlywaspredictive,with a balanced accura-
cy of 83%, of whether he or she was also misclustered. This agreement
was much higher than what would be expected by chance (posterior
infraliminal probability p b 0.001). We found no indication that
misclusteringwas simply a result of ill-ﬁttingmodels; there was no sig-
niﬁcant difference in R2 between correctly and incorrectly clustered pa-
tients (p = 0.177).
The above model-based classiﬁcation and clustering results are
reassuring, but they ultimately only provide a conﬁrmation of a diag-
nostic category that is already known and that can be assessed much
easier by means of a conventional clinical interview. Instead, the real
question of interest is whether the schizophrenic spectrum as deﬁned
by DSM-IV may contain neurophysiologically distinct subgroups that
are revealed by a model-based characterisation. This motivated the
ﬁnal analysis in which we focussed on the group of patients alone to
avoid that more subtle differences amongst the patients could be
swamped by more pronounced differences between patients and
controls.
3.3. Model-based clustering of patients
Applying model-based clustering exclusively to the group of partic-
ipants diagnosed with schizophrenia, we obtained the highest model
evidence for a clustering solution with three clusters (Fig. 5a), and
model comparison provided very strong evidence that this solution
was better than the next-bestmodel, which contained only two clusters
(log BF = 29.1). This ﬁnding indicates that removing the healthy con-
trols from the analysis unmasked a more subtle distinction among pa-
tients, dissecting the schizophrenic spectrum into three distinct
clusters.
The identiﬁed clusters comprised 22% (n = 9), 59% (n = 24), and
17% (n = 7) of patients, respectively. Critically, since theywere deﬁned
in terms of a DCM-based generative score space, differences between
clusters can be examined in terms of the neuronal circuit models they
imply. Fig. 5b illustrates graphically the mean parameter estimates
across all subjects within each of the three clusters (see Table 1 for de-
tails). This juxtaposition highlights that the three identiﬁed subgroups
of patients differed in terms of themechanisms embodied by ourmodel.
Perhaps most striking were the different patterns of modulatory in-
ﬂuence exerted by increasing demands on working memory across the
three subgroups. Speciﬁcally, both the ﬁrst and the third subgroup
showed a strengthening of the visual–prefrontal and the prefrontal–
parietal connection under increasing working-memory demands, but
the relative strength of thesemodulatory effects was reversed: working
memory primarily enhanced the prefrontal–parietal connection in the
ﬁrst subgroup and the visual–prefrontal connection in the third
subgroup. By contrast, the second subgroup showed a weakening of
prefrontal–parietal connectivity under increasingworking-memory de-
mands and a concomitant increase in the visual–prefrontal connection.
This suggests that working memory leads to tighter functional integra-
tion of the three areas in theﬁrst and third subgroupwhile causing a rel-
ative re-routing of visual information to the prefrontal cortex and a
relative decoupling of parietal from prefrontal cortex in the second
subgroup.
3.4. Validation of the clustering solution
Finally, we evaluated the construct validity of the identiﬁed sub-
groups. In other words, we testedwhether the neurophysiologically de-
ﬁned subgroups proposed by ourmodel-based clustering solution could
be mapped onto variations in known clinical variables. For this data set,
we had access to two clinical variables of interest: (i) chlorpromazine
equivalents (CPZ) as a measure of medication (where higher values
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correspond to stronger doses); and (ii) scores on the positive and nega-
tive syndrome scale (Kay et al., 1987) as a measure of symptom severity
in patients with schizophrenia (where higher values correspond to
more severe symptoms).
Carrying out a one-way ANOVA separately for these two variables,
no signiﬁcant differences in CPZ equivalents were found among sub-
groups (p = 0.96). By contrast, PANSS scores differed between the sub-
groups. Speciﬁcally, we found signiﬁcant differences in the ‘negative
symptoms’ (NS) subscale (p b 0.05). As shown in Fig. 5c, patients in
the three clusters scored 15.6 ± 2.3, 19.6 ± 1.4, and 27.9 ± 4.1
(mean ± SD) on this scale. In other words, patients in the second clus-
ter showed an average negative symptom severity that was close to the
overall mean in the group of patients; whereas patients in the ﬁrst and
third cluster tended to score below and above this group average, re-
spectively. One could ask (as did one of our reviewers) whether this re-
lation betweenDCMparameter estimates and PANSS-NS scores can also
be found in a supervised analysis. Indeed, a multiple linear regression
analysis (with PANSS-NS scores as dependent and DCM parameter esti-
mates as independent variables) across all 40 patients with PANSS
scores conﬁrmed the statistical relationship between model parameter
estimates and external labels (p = 0.008; F = 3.02 on 12 and 27 d.f.;
R2 = 57.3%).
The above relation between the functional architecture of our three-
region circuit and a speciﬁc PANSS subscale is intriguing and ﬁts nicely
with recent reports demonstrating a systematic relationship between
working memory performance and severity of negative symptoms.
For example, neuropsychological studies by Pantelis et al. (2001) and
Pantelis et al. (2004) demonstrated a signiﬁcant inverse relation be-
tween (spatial) working memory performance and the degree of nega-
tive symptoms. More recently, the same relationship was also
demonstrated for the n-back task, as used in our study, by Barr et al.
(2010). Finally, in a longitudinal study of ﬁrst-episode schizophrenic
patients, González-Ortega et al. (2013) showed that initial working
memory performance predicted the degree of negative symptoms
after a 5-year follow-up. Themapping of neurophysiologically informed
subgroups based on our three-region working-memory network onto
clinical subgroups that differ in negative symptom severity may there-
fore be a promising target for longitudinal studies, especially given
that conventional treatment strategies have largely failed to reduce
working-memory deﬁcits and negative symptoms (Hyman and
Fenton, 2003; Lieberman et al., 2005).
Given the link betweenworking-memory performance and negative
symptoms, one might wonder whether our neurophysiologically de-
ﬁned subgroups simply represented patients that differed in working
memory capacity. To test whether the correspondence between our
DCM-based clustering results and the PANSS-NS scores could be
explained away by differences in working-memory, we carried out an-
other ANOVA based on the difference between 2-back and 0-back
working-memory performance.We found no signiﬁcant differences be-
tween clusters (p = 0.144).
For completeness and comparison, we repeated all clustering analy-
ses for the two feature sets which had proven less powerful than DCM
parameter estimates for distinguishing between patients and controls
in our initial supervised classiﬁcation analysis, i.e., regional activity
and functional connectivity. The results are summarised in Fig. 6. In
brief, GMM-based clustering of all subjects, using either regional activity
or functional connectivity, indicated the presence of two groups, as was
the case when using effective connectivity. However, the relative evi-
dence for two, compared to fewer or more clusters, was considerably
weaker than in our original analysis on the basis of DCM parameters
(see the proﬁle of log evidences in Figs. 4c and 6a,b). Accordingly, as
one might expect, the two clusters did not map onto patients and con-
trols, as indicated by a balanced purity insigniﬁcantly different from
0.5 (Fig. 6a,b). Furthermore, clustering of the patients only led to two
subgroups (Fig. 6c,d). Again, however, the relative evidence for this
number of subgroups was considerably weaker than in the original
model-based analysis (Fig. 5a); and the identiﬁed subgroups did not
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Fig. 5.Model-based clustering (generative embedding) of patients. Thisﬁgure summarises the results of an unsupervised clustering analysis of the patient group only, using Gaussianmix-
ture models operating on DCM parameter estimates. Panel a plots the log evidence for models assuming different numbers of clusters, showing that there is highest evidence for three
subgroups of schizophrenic patients. Panel b summarises the average posterior parameter estimates (in terms ofmaximum a posteriori estimates) for each coupling and input parameter
in themodel. This is displayed graphically by thewidth of the respective arrows. Panel c demonstrates that the three subgroups,which are deﬁned on thebasis of connection strengths, also
differ in terms of negative clinical symptoms as operationalised by the negative symptoms (NS) subscale of the PANSS score.
Table 1
Connectivity within the three identiﬁed patient clusters. The table summarizes the
connectivity of the three clusters identiﬁed by Gaussian mixture modelling of the 41
individual dynamic causal models of patients with schizophrenia. Each row shows
a particular model parameter. All parameter estimates are given in terms of
mean ± standard error across the patients contained in each cluster. For a graphical
interpretation of the means, see Fig. 5b.
Model parameter Cluster 1 (n = 9) Cluster 2 (n = 24) Cluster 3 (n = 7)
VC self-connection −1.000 ± 0.001 −0.994 ± 0.003 −1.001 ± 0.004
VC→ PC 0.036 ± 0.022 0.070 ± 0.036 0.044 ± 0.025
VC→ DLPFC 0.055 ± 0.029 0.044 ± 0.018 0.130 ± 0.068
PC→ VC 0.017 ± 0.001 0.014 ± 0.004 0.017 ± 0.002
PC self-connection −1.000 ± 0.000 −0.994 ± 0.004 −0.999 ± 0.001
PC→ DLPFC 0.017 ± 0.001 0.014 ± 0.005 0.024 ± 0.007
DLPFC→ VC 0.043 ± 0.026 0.021 ± 0.02 0.019 ± 0.004
DLPFC→ PC 0.042 ± 0.024 0.034 ± 0.012 0.023 ± 0.008
DLPFC self-connection −0.997 ± 0.003 −0.998 ± 0.001 −0.996 ± 0.003
WMmodulation of
VC→ DLPFC
0.110 ± 0.227 0.124 ± 0.102 0.267 ± 0.135
WMmodulation of
DLPFC→ PC
0.204 ± 0.191 −0.023 ± 0.017 0.071 ± 0.064
Direct input to VC 0.073 ± 0.043 0.074 ± 0.043 0.104 ± 0.020
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map onto signiﬁcant differences in clinical symptoms (p = 0.73 and
p = 0.98, respectively; one-way ANOVA; Fig. 6c,d).
4. Discussion
In this proof-of-concept study, we extended the recently introduced
generative-embedding approach for model-based classiﬁcation to the
unsupervised domain, with a particular focus on the question of how
model-based clustering could be used to dissect psychiatric spectrum
diseases into physiologically deﬁned subgroups. Using a recently pub-
lished fMRI dataset of schizophrenic patients and healthy controls
performing an n-back working-memory task (Deserno et al., 2012),
we found that generative embedding, based on a simple three-region
DCM of prefrontal-parietal-visual areas, led to signiﬁcantly better re-
sults for both supervised learning (classiﬁcation) and unsupervised
learning (clustering), compared to estimates of functional connectivity
or regional activity.
When applied to the patient group alone, generative embedding
suggested the existence of three schizophrenic subgroups which were
distinguished by differences in network architecture, i.e., the pattern
of effective connectivity amongprefrontal, parietal, and visual areas. Im-
portantly, even though the deﬁnition of these clusterswas not informed
by any information on clinical symptoms but only by the fMRI data, the
three subgroups showed signiﬁcantly different average PANSS scores
(Fig. 5). In other words, our unsupervised model-based clustering pro-
cedure identiﬁed three neurophysiologically distinct subgroups which
mapped onto clinical status. No such correspondence between neuro-
physiology and symptomswas foundwhen using either functional con-
nectivity estimates or regional activity for clustering (Fig. 6).
One may think that a trivial reason for the superiority of the model-
based approach in this application is access tomore information, i.e., the
analyses based on effective connectivity are based on more features
than the analyses based on functional connectivity (posterior means
of parameter estimates vs. correlation coefﬁcients). However, this over-
looks that in our embedding approach the choice of feature space is a di-
rect consequence of the different assumptions (made by DCM and
functional connectivity analyses, respectively) about what constitutes
an appropriate low-dimensional summary or sufﬁcient statistics of a
network. While DCM posits that a minimal network description in-
cludes directed inter-regional inﬂuences and theirmodulation by exter-
nal perturbations (e.g., task conditions), functional connectivity (as
implemented here) only cares about undirected coupling and rests on
pair-wise correlation coefﬁcients. Second, and perhaps even more im-
portantly, more data features are not necessarily better: the generaliz-
ability of classiﬁcation and clustering results often starts to decline as
the number of features increases, due to overﬁtting. Indeed, the third
type of analysis considered here, based on regional activity was based
on twice as many features as functional connectivity, but performed
less well (Fig. 4a). Finally, as we demonstrated in previous work
(Brodersen et al., 2011a,b), the superiority of a model-based approach
to classiﬁcation critically depends on the quality of its assumptions: in
the absence of a good model (or when deliberately compromising
model quality), a simpler summary of network dynamics in terms of
functional connectivity may be more appropriate and lead to better
classiﬁcation results. In summary, the classiﬁcation/clustering perfor-
mance differences of the three different approaches considered here
cannot be reduced to differences in the dimensionality of feature
spaces; instead, they critically depend on how this feature space was
constructed, based on different notions about what constitutes the suf-
ﬁcient statistics of a network.
This superiority of themodel-based approach is in accordancewith a
previous classiﬁcation study by Brodersen et al. (2011a,b) where
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Fig. 6. Clustering solutions based on regional activity or functional connectivity. Panels (a) and (b) report the results of repeating the unsupervised clustering analysis of all subjects
(cf. Fig. 4c), using estimates of regional activity and functional connectivity, respectively. In contrast to theprocedurebased ongenerative embedding, using regional activity and functional
connectivity as data features provided weaker relative evidence for two clusters, and these two clusters did not map onto patients and controls (balanced purity insigniﬁcantly different
from0.5). Panels (c) and (d) show the results of a clustering analysis of patients only (cf. Fig. 5), using regional activity and functional connectivity. In contrast to the generative-embedding
solution, these analyses suggest the existence of two (as opposed to three) patient subgroups. However, in neither case did the suggested subgroups map onto signiﬁcant differences in
clinical symptoms as measured by the PANSS score.
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generative embedding based on DCM signiﬁcantly outperformed classi-
ﬁcation based on functional connectivity or various aspects of regional
activity. One plausible reason for this consistentﬁnding is that estimates
of effective connectivity aremore robust to noise, and variability thereof
across regions, than functional connectivity estimates (for a detailed
discussion of this issue, see Friston, 2011). Generally, a generative
model like DCM separates the measured time series into a predicted
component (which is encoded by the model parameters) and unex-
plained residuals (which represents an estimate of the noise). By har-
vesting parameter estimates and using these to construct a generative
score space, we therefore discard estimates of unexplained noise and
restrict classiﬁcation to those parts of the signalwhich have amechanis-
tic explanation (under the assumptions of the model). In other words,
by exploiting the very speciﬁc denoising effect of ﬁtting a mechanistic
model, classiﬁcation and clustering operate in a more meaningful
space and may be more resilient against noise and irrelevant features.
In this study, we have presented a simple generative model of effec-
tive connectivity between three regions whose parameters deﬁned pa-
tient subgroups which mapped nicely onto a differences in symptom
severity.Wedonotwish to claim that this is the best neurophysiological
model one could have devised in order to dissect the spectrum of our
schizophrenic patients. Clearly, it would have been possible to consider
other mathematical formulations and variants or extensions of the cir-
cuit we have considered here. Indeed, in addition to Deserno et al.
(2012), numerous other studies have reported connectivity differences
during working memory between schizophrenia and healthy controls
(Cole et al., 2011; He et al., 2012; Kim et al., 2009; Meda et al., 2009;
Rasetti et al., 2011; Repovš and Barch, 2012; Yoon et al., 2013), with
some studies highlighting additional brain regions such as the hippo-
campus or basal ganglia. Here, we focused on the interactions between
early visual, parietal, and prefrontal regions; this choice was guided by
the voxel-wise analyses by Deserno et al. (2012) for the same data
and additionally motivated by the recent meta-analysis of Rottschy
et al. (2012)which had emphasised the importance of dorsolateral pre-
frontal and parietal cortex for working memory.
Which particular model should be preferred for suggesting a neuro-
physiologically inspired classiﬁcation can be evaluatedwith regard to its
predictive validity for clinical decision making. Such an evaluation in-
volves testing the suggested classiﬁcation against clinical benchmarks
in longitudinal studies, such as the degree to which the model can pre-
dict individual outcome and individual treatment response (see below).
More generally, generative embedding suggests an alternative to Bayes-
ian model selection (BMS) for deciding which of several candidate
model ﬁts best.While BMS evaluates the evidence of competingmodels
against the same data, generative embedding would rank models in
terms of their predictive validity against an external criterion. Both of
these approaches have advantages and limitations which are discussed
in more detail by Brodersen et al. (2011a,b).
While our study has provided a concrete example that the concept
of generative embedding may be useful for splitting psychiatric spec-
trum diseases into neurophysiologically deﬁned subgroups, it has a
number of important limitations. Perhaps most important is the lack
of a longitudinal study design which would allow us to test the pro-
posed cluster structure against future clinical variables. For example, it
would be convincing and of considerable clinical utility if one found
that model-derived neurophysiological subgroups mapped onto
treatment-response proﬁles such as, for example, differential sensitivity
to alternative medication options. In our cross-sectional design, we
were unable to validate the proposed subgroups with regard to such
variables (although we were able to rule out that patients assigned to
the three subgroups had signiﬁcantly different medication in terms of
chlorpromazine equivalents).
A second limitation of this study is the type of model used for
generative embedding, i.e., a deterministic bilinear DCM for fMRI,
which can only provide a rather coarse summary of neurophysiolog-
ical mechanisms in terms of synaptic coupling between large,
undifferentiated neuronal populations. This restriction in conceptual
resolution is mainly due to the nature of the fMRI signal which
makes it difﬁcult to infer on detailed synaptic mechanisms, such as
the contribution of different neurotransmitter systems. Having said
this, a number of fMRI studies have demonstrated that, despite the
limitations of the BOLD signal, surprisingly precise predictions with
clinical utility can be made using DCM, such as inferring the driver
of epileptic activity (David et al., 2008) or recognising the presence
or absence of dopaminergic medication in patients with Parkinson's
disease (Rowe et al., 2010).
Beyond fMRI, even more detailed synaptic mechanisms, such as
spike-frequency adaptation or conduction delays, can potentially be
inferred by suitably deﬁned DCMs operating on electrophysiological
data. For example, in pharmacological studies in both rodents and
humans, dynamic causal modelling of the conventional neural mass
model type was able to recognise anaesthesia-induced shifts in the bal-
ance of excitatory and inhibitory synaptic signalling (Moran et al.,
2011a,b). Furthermore, a conductance-based DCM of a prefrontal corti-
cal column succeeded in detecting experimentally induced inﬂuences of
dopamine on NMDA and AMPA receptor-mediated postsynaptic re-
sponses at glutamatergic synapses (Moran et al., 2011a,b). The latter
model offers intriguing opportunities for futuremodel-based prediction
studies in schizophrenia given that it aims to quantify a physiological
process (i.e., dopaminergic inﬂuence on glutamatergic signalling)
which possesses a direct link to both pathophysiological theories
(cf. the dis-/dysconnection hypothesis; Friston, 1998; Stephan et al.,
2009) and treatment options in schizophrenia. Another promising
extensionmay be to construct model-based analyses that rest on a com-
bination of dynamical systemmodels of neurophysiologywith computa-
tional models of behaviour (e.g., Den Ouden et al., 2010). An example of
behavioural models that are also of a generative nature and therefore
suitable for such a combined approach are meta-Bayesian models of
learning and decision making (e.g., Daunizeau et al., 2010; Mathys
et al., 2011). This combined approach has great potential for enabling
what one might refer to as neurocomputational generative embedding,
affording classiﬁcation and clustering results with both behavioural
and neurophysiological interpretability.
It is worth emphasising that this paper should not bemisunderstood
as arguing for a purely categorical classiﬁcation and against a dimen-
sional construct of psychiatric diseases. While this is a complicated
issue with a long history (cf. Allardyce et al., 2007; Cloninger et al.,
1985; Demjaha et al., 2009; Everitt et al., 1971) which we cannot
cover in detail here, we would like to emphasise that under any per-
spective that postulates a mapping from the state of neuronal circuits
to phenomenology, categorical and dimensional perspectives naturally
coexist and complement each other. For example, at the circuit level
represented by the type of model used in this study, each parameter
(such as those encoding the strength of a particular synaptic connec-
tion) lives on a continuous scale, and thus any particular aspect of the
patient's symptoms affected by this particular parameter is best under-
stood as a dimensional construct. Nevertheless, within the space
spanned by the circuit's parameters, certain conﬁgurations (parameter
vectors) may occur more frequently across subjects than others, thus
forming clusters which can be understood as neurophysiologically de-
ﬁned categories of the disease state overall. In general, subgroups like
those found in the present study should be scrutinized by future longi-
tudinal studies, speciﬁcally designed to test for differences in clinically
meaningful outcome variables, such as response to a particular treat-
ment. This could provide a useful strategy towards a revised nosology
based on mechanistic accounts with concrete treatment implications,
irrespective of whether one prefers a dimensional or categorical per-
spective on the underlying model.
Regarding the statistical approach chosen in the present study, one
can imagine an alternative strategy that uniﬁesmechanistically inspired
modelling of the observed data and classiﬁcation or clustering within a
single generative model. This would require a model describing how
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clinical outcomes depend on hidden (latent) neurophysiological mech-
anisms which themselves depend on underlying causes (disease sub-
groups) whose cardinality is unknown and must be inferred, either by
Bayesian model selection (in the same way as was done in the case of
a GMM in the present paper) or, by adopting a nonparametric Bayesian
approach, jointly with the parameters of the neurophysiological model.
Such potential extensions are the topic of ongoing work in our group.
Uniﬁed generativemodels of this sort could reduce the two steps of gen-
erative embedding and classiﬁcation or clustering (steps 3 and 4 in
Fig. 1) to a single step of model inversion. On the other hand, similar
to group analyses in which a second-level test on ﬁrst-level summary
statistics often provides a close approximation to full hierarchical
mixed-effects models (Brodersen et al., 2012; Mumford and Nichols,
2009), it could turn out that generative embedding is simpler and
more robust than inverting the uniﬁed generative model sketched out
above. Whichever statistical machinery is chosen, given the promising
potential shown by its initial applications to classiﬁcation (Brodersen
et al., 2011a,b) and clustering (this study), we anticipate that model-
based analyses of this sortwill serve as a useful framework for future ap-
plications of machine learning and computational neuroscience to
psychiatry.
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Appendix A
Variational Gaussian mixture model
This section details the prior parameterization we use to obtain a
variational Bayesian solution to the Gaussian mixture model used in
the main text. To begin with, we deﬁneWishart priors on the precision
matrices Λ and Gaussian priors on the means μ (conveniently
parameterised as conditional priors given the respective prior preci-
sions). Further, we deﬁne a diffuse Dirichlet prior over the mixing coef-
ﬁcients π. In summary:
p Λð Þ ¼∏Kk¼1W ΛkjW0;ν0ð Þ ð1Þ
p μjΛð Þ ¼∏Kk¼1N μkjmo; β0Λkð Þ−1
 
ð2Þ
p πð Þ ¼ Dir πjα0ð Þ: ð3Þ
Using this parameterisation, the only approximating assumption re-
quired to obtain a variational solution is the mean-ﬁeld assumption
q Z;π; μ;Λð Þ ¼ q Zð Þq π; μ;Λð Þ; ð4Þ
where q(⋅) is the desired variational approximation to the true posterior
p(⋅|X). To ﬁnd the optimal variational posterior q*(⋅), the algorithm iter-
ates between a variational E-step,
lnq Zð Þ ¼ lnp X; Z;π; μ;Λð Þh iq π;μ;Λð Þ; ð5Þ
and a variational M-step,
lnq π; μ;Λð Þ ¼ lnp X; Z; π; μ;Λð Þh iq Zð Þ: ð6Þ
Critically, this approach enables us to determine the optimal number
of clusters by means of Bayesian model selection. Speciﬁcally, we can
compute a free-energy bound to the log model evidence
lnp Xð Þ ¼ ln∭p XjZ;π; μ;Λð Þp Z;π; μ;Λð Þd Zd πd μd Λ
¼ KL q∥p½  þ F q;Xð Þ
≥ lnp X; Z; π; μ;Λð iqþH q½ :
D ð7Þ
In the above equation, we have expressed the logmodel evidence as
the sum of: the Kullback–Leibler divergence KL[q ∥ p] between the ap-
proximate posterior q = q(Z,π,μ,Λ) and the true posterior p ≡ p(Z, π,
μ, Λ|X); and the negative free energy F(q,X). Maximising the negative
free energyminimises the KL-divergence and thus leads to a maximally
close approximation to the true posterior. The free energy itself can be
easily evaluated for a given q as the sum of: the expected log joint distri-
bution over the data and the parameters 〈 ln p(X,Z,π,μ,Λ〉q; and the
Shannon entropy of the approximate posterior, H[q].
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